Epidemiological and clinical features of malignant hyperthermia: A scoping review.
Cong Z, Wan T, Wang J, Feng L, Cao C, Li Z, Wang X, Han Y, Zhou Y, Gao Y, Zhang J, Qu Y, Guo X.
Cong Z, et al.
Clin Genet. 2024 Mar;105(3):233-242. doi: 10.1111/cge.14475. Epub 2023 Dec 26.
Clin Genet. 2024.
PMID: 38148504
Review.
Malignant hyperthermia (MH) is a potentially fatal inherited pharmacogenetic disorder related to pathogenic variants in the RYR1, CACNA1S, or STAC3 genes. ...The most frequent initial clinical signs included hyperthermia, sinus tachycardia, and hypercarbia. T …
Malignant hyperthermia (MH) is a potentially fatal inherited pharmacogenetic disorder related to pathogenic variants in the RY …